Apremilast
PrintQuick read
Apremilast is not often used during pregnancy because there is not enough evidence to say it is safe for the baby.
What is it?
Apremilast (Otezla®) is most commonly used to treat psoriasis and psoriatic arthritis, as well as mouth ulcers caused by Behçet’s disease.
Benefits
What are the benefits of using apremilast?
Apremilast can help keep inflammatory arthritis under control, which may reduce your symptoms and help prevent damage to your joints. It can also improve your health and wellbeing by keeping psoriasis and mouth ulcers under control.
However, apremilast is not recommended during pregnancy because there is not enough information to confirm that it is safe for your baby.
Risks
Are there any risks of using apremilast in pregnancy?
There is no information available about women who have taken apremilast during pregnancy, so it is unclear whether it can harm the baby.
Alternatives
Are there any alternatives to using apremilast in pregnancy?
Yes. If you are planning a pregnancy, your specialist will usually advise you to stop apremilast treatment. You may be offered a different medicine that is known to be safer during pregnancy.
No treatment
What if I prefer not to take medicines during pregnancy?
Your doctor will be happy to discuss any concerns about medicines prescribed during pregnancy.
Will my baby need extra monitoring?
As part of routine antenatal care, you will usually be offered a detailed scan at around 20 weeks of pregnancy to check your baby’s development. Women who have taken apremilast during pregnancy may be offered this scan from around 16 weeks.
Who can I talk to if I have questions?
If you have any questions about the information in this leaflet, please discuss them with your healthcare provider. They can access more detailed medical and scientific information from www.uktis.org.